Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53,041,500
-
Total 13F shares
-
29,212,104
-
Share change
-
+1,224,725
-
Total reported value
-
$269,093,210
-
Put/Call ratio
-
208%
-
Price per share
-
$9.21
-
Number of holders
-
122
-
Value change
-
+$5,557,027
-
Number of buys
-
67
-
Number of sells
-
50
Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q4 2023
As of 31 Dec 2023,
Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) was held by
122 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,212,104 shares.
The largest 10 holders included
CAS Investment Partners, LLC, BlackRock Inc., VANGUARD GROUP INC, 683 Capital Management, LLC, KPS Global Asset Management UK Ltd, WORLDLY PARTNERS MANAGEMENT, LLC, MORGAN STANLEY, BAILLIE GIFFORD & CO, GEODE CAPITAL MANAGEMENT, LLC, and BRIGHTLIGHT CAPITAL MANAGEMENT LP.
This page lists
122
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.